Early detection of nasopharyngeal carcinoma
- PMID: 21716698
- PMCID: PMC3118637
- DOI: 10.1155/2011/638058
Early detection of nasopharyngeal carcinoma
Abstract
Nasopharyngeal carcinoma (NPC) is a unique disease with a clinical presentation, epidemiology, and histopathology differing from other squamous cell carcinomas of the head and neck. NPC is an Epstein-Barr virus-associated malignancy with a marked racial and geographic distribution. Specifically, it is highly prevalent in southern China, Southeast Asia, and the Middle East. To date, most NPC patients have been diagnosed in the advanced stage, but the treatment results for advanced NPC are not satisfactory. This paper provides a brief overview regarding NPC, with the focus on the early detection of initial and recurrent NPC lesions.
References
-
- Sham JST, Wei WI, Yong-Sheng Z, et al. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy. The Lancet. 1990;335(8686):371–374. - PubMed
-
- Agulnik M, Epstein JB. Nasopharyngeal carcinoma: current management, future directions and dental implications. Oral Oncology. 2008;44(7):617–627. - PubMed
-
- Fandi A, Altun M, Azli N, Armand JP, Cvitkovic E. Nasopharyngeal cancer: epidemiology, staging, and treatment. Seminars in Oncology. 1994;21(3):382–397. - PubMed
-
- Homepage of Surveillance Epidemiology and End Results (SEER) Program. U.S. National Cancer Institute.
-
- Huang DP. Epidemiology of nasopharyngeal carcinoma. Ear, Nose and Throat Journal. 1990;69(4):222–224. - PubMed
LinkOut - more resources
Full Text Sources
